Cargando…

Targeted Delivery to Tumor-associated Pericytes via an Affibody with High Affinity for PDGFRβ Enhances the in vivo Antitumor Effects of Human TRAIL

Human tumor necrosis factor-related apoptosis-inducing ligand (hTRAIL) has exhibited superior in vitro cytotoxicity in a variety of tumor cells. However, hTRAIL showed a disappointing anticancer effect in clinical trials, although hTRAIL-based regimens were well tolerated. One important reason might...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Ze, Yang, Hao, Shi, Qiuxiao, Fan, Qing, Wan, Lin, Lu, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505058/ https://www.ncbi.nlm.nih.gov/pubmed/28740549 http://dx.doi.org/10.7150/thno.19091

Ejemplares similares

PDGFRβ-specific affibody-directed delivery of a photosensitizer, IR700, is efficient for vascular-targeted photodynamic therapy of colorectal cancer
por: Shi, Qiuxiao, et al.
Publicado: (2017)

Preclinical evaluation of (68)Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma
por: Cai, Huawei, et al.
Publicado: (2023)

Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects
por: Yang, Hao, et al.
Publicado: (2018)

CD146 is essential for PDGFRβ-induced pericyte recruitment
por: Chen, Jianan, et al.
Publicado: (2017)

Interferon-γ blocks signalling through PDGFRβ in human brain pericytes
por: Jansson, Deidre, et al.
Publicado: (2016)

M2 Macrophages Promote PDGFRβ(+) Pericytes Migration After Spinal Cord Injury in Mice via PDGFB/PDGFRβ Pathway
por: Li, Ziyu, et al.
Publicado: (2021)

Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities
por: Pan, Li-Qiang, et al.
Publicado: (2015)

Elevated PDGF‐BB from Bone Impairs Hippocampal Vasculature by Inducing PDGFRβ Shedding from Pericytes
por: Liu, Guanqiao, et al.
Publicado: (2023)

Spatiotemporal dynamics of PDGFRβ expression in pericytes and glial scar formation in penetrating brain injuries in adults
por: Reeves, C., et al.
Publicado: (2019)

Characterisation of PDGF-BB:PDGFRβ signalling pathways in human brain pericytes: evidence of disruption in Alzheimer’s disease
por: Smyth, Leon C. D., et al.
Publicado: (2022)

Ursodeoxycholic Acid Attenuates the Retinal Vascular Abnormalities in Anti-PDGFR-β Antibody-Induced Pericyte Depletion Mouse Models
por: Shiraya, Tomoyasu, et al.
Publicado: (2020)

Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer
por: She, Tianshan, et al.
Publicado: (2021)

Specific ablation of PDGFRβ-overexpressing pericytes with antibody-drug conjugate potently inhibits pathologic ocular neovascularization in mouse models
por: Lee, Seok Jae, et al.
Publicado: (2021)

Immunolocalization of platelet‐derived growth factor receptor‐β (PDGFR‐β) and pericytes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
por: Craggs, Lucinda J.L., et al.
Publicado: (2015)

PEG Linker Improves Antitumor Efficacy and Safety of Affibody-Based Drug Conjugates
por: Li, Qiyu, et al.
Publicado: (2021)

Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway
por: Wang, Yi-Chun, et al.
Publicado: (2019)

Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Aβ-Affibodies
por: Faresjö, Rebecca, et al.
Publicado: (2022)

A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy
por: Li, Zhao, et al.
Publicado: (2022)

Pericyte-Mediated Tissue Repair through PDGFRβ Promotes Peri-Infarct Astrogliosis, Oligodendrogenesis, and Functional Recovery after Acute Ischemic Stroke
por: Shibahara, Tomoya, et al.
Publicado: (2020)

Imatinib inhibits pericyte-fibroblast transition and inflammation and promotes axon regeneration by blocking the PDGF-BB/PDGFRβ pathway in spinal cord injury
por: Yao, Fei, et al.
Publicado: (2022)

PDGFR‐β and kidney fibrosis
por: Ortiz, Alberto
Publicado: (2020)

Interface-Based Design of High-Affinity Affibody Ligands for the Purification of RBD from Spike Proteins
por: Song, Siyuan, et al.
Publicado: (2023)

Transactivation of PDGFRβ by dopamine D4 receptor does not require PDGFRβ dimerization
por: Chi, Sum Shing, et al.
Publicado: (2010)

Affibody-Binding Ligands
por: Barozzi, Annalisa, et al.
Publicado: (2020)

PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα
por: Fantauzzo, Katherine A., et al.
Publicado: (2016)

Prokaryotic expression of antibodies and affibodies
por: Fernández, Luis Angel
Publicado: (2004)

Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells
por: Wu, Erxi, et al.
Publicado: (2008)

An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells
por: Romanelli, Alessandra, et al.
Publicado: (2018)

Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats
por: Pozdzik, Agnieszka A., et al.
Publicado: (2016)

MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer
por: Garofalo, Michela, et al.
Publicado: (2013)

DNA–affibody nanoparticle delivery system for cisplatin-based breast cancer chemotherapy
por: Zhang, Chao, et al.
Publicado: (2019)

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer
por: Garofalo, Michela, et al.
Publicado: (2015)

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer
por: Garofalo, Michela, et al.
Publicado: (2022)

Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake
por: Rosestedt, Maria, et al.
Publicado: (2019)

Affibody molecules as engineered protein drugs
por: Frejd, Fredrik Y, et al.
Publicado: (2017)

In vivo depletion of serum IgG by an affibody molecule binding the neonatal Fc receptor
por: Seijsing, Johan, et al.
Publicado: (2018)

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
por: Liu, Haipeng, et al.
Publicado: (2017)

Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity
por: Fleetwood, Filippa, et al.
Publicado: (2014)

ARF sees Pdgfrβ through the miR
por: Reed, Sara M, et al.
Publicado: (2014)

Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
por: Buhl, Eva M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ffue91oim68d98210lsjbb6mj2